BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15002118)

  • 1. Nonsurgical treatment of laryngeal cancer.
    Guntinas-Lichius O
    N Engl J Med; 2004 Mar; 350(10):1049-53; author reply 1049-53. PubMed ID: 15002118
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonsurgical treatment of laryngeal cancer.
    Weinstein GS; Myers EN; Shapshay SM; Weber R
    N Engl J Med; 2004 Mar; 350(10):1049-53; author reply 1049-53. PubMed ID: 14999119
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsurgical treatment of laryngeal cancer.
    Langer M
    N Engl J Med; 2004 Mar; 350(10):1049-53; author reply 1049-53. PubMed ID: 15002116
    [No Abstract]   [Full Text] [Related]  

  • 4. Organ preservation therapy for advanced-stage laryngeal carcinoma.
    Hoffman HT; McCulloch T; Gustin D; Karnell LH
    Otolaryngol Clin North Am; 1997 Feb; 30(1):113-30. PubMed ID: 8995140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options for laryngeal cancer.
    Vokes EE; Stenson KM
    N Engl J Med; 2003 Nov; 349(22):2087-9. PubMed ID: 14645634
    [No Abstract]   [Full Text] [Related]  

  • 6. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of laryngeal cancer: the permanent challenge.
    Lefebvre JL; Coche-Dequéant B; Degardin M; Kara A; Mallet Y; Ton Van J
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):913-20. PubMed ID: 15485324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation.
    Hanna E; Sherman A; Cash D; Adams D; Vural E; Fan CY; Suen JY
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):875-9. PubMed ID: 15262766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsurgical treatment of laryngeal cancer.
    Gupta T; Agarwal J; Lashkar SG
    N Engl J Med; 2004 Mar; 350(10):1049-53; author reply 1049-53. PubMed ID: 15002115
    [No Abstract]   [Full Text] [Related]  

  • 11. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ preservation surgery for laryngeal cancer.
    Tufano RP; Stafford EM
    Otolaryngol Clin North Am; 2008 Aug; 41(4):741-55, vi. PubMed ID: 18570956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative assessment of the five-year results of surgical, combined, radiation and chemoradiotherapy in laryngeal cancer (T3N0M0)].
    Tkachëv SI; Matiakin EG; Liubaev VL; Boĭkov VP; Alieva SB; Aliev BM; Kondrat'eva AP; Aketova TA; Pirogova NA; Loginova IN
    Vopr Onkol; 2006; 52(4):404-7. PubMed ID: 17024811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laryngeal cancer today compared to a study 50 years ago.
    McNelis FL; Nigri PT
    Med Health R I; 2011 Oct; 94(10):300-1. PubMed ID: 22164661
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonsurgical treatment of laryngeal cancer.
    Haddad RI; Tishler RB; Posner MR
    N Engl J Med; 2004 Mar; 350(10):1049-53; author reply 1049-53. PubMed ID: 15002117
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction chemotherapy for larynx preservation: patient selection or therapeutic effect?
    Pfister DG; Ridge JA
    J Clin Oncol; 2006 Feb; 24(4):540-3. PubMed ID: 16380409
    [No Abstract]   [Full Text] [Related]  

  • 17. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA; Trotti AM
    J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.